426 Spam-Free Article(s) Found
Sep 08, 2015 - Endocyte, Inc. (ECYT) announced positive results from the final overall survival analysis from the phase IIb TARGET study on Vynfinit for non-small cell lung cancer.
Sep 02, 2015 - Regeneron Pharmaceuticals, Inc. (REGN) and its partner Sanofi (SNY) presented encouraging data from a phase III study on their Praluent, at the ESC Congress 2015.
Sep 01, 2015 - Sanofi (SNY) and the life sciences team at Google are collaborating for improving care and outcomes for patients with type I and type II diabetes.
Sep 01, 2015 - Given the alarming rise in the diabetic patient population every year, Google Inc.'s (GOOGL) life sciences group has partnered with the French drug maker Sanofi (SNY) to develop tools to enhance holistic diabetes management and treatment worldwide.
Aug 28, 2015 - Will FDA approval of Amgen's (AMGN) Repatha trigger a pricing war for this class of treatment?
Aug 27, 2015 - Oncolytics Biotech (ONCY) completed enrolling patients in a phase II study on Reolysin for the treatment of non-small cell lung cancer.